Genius of the Rules-Style System

Chapter 667: Chapter 374: Wishing You Success, Keep Going! _3

This is the lab’s drug cost.

Market sales need to take into account R&D costs, profits, etc., so it’s easy for the price to increase several times or even dozens of times, making it unaffordable for ordinary people.

Pharmaceutical companies have an even bigger concern.

Once the drug officially enters the market, the ingredients will be made public, and imitations will soon emerge. Some international pharmaceutical companies have stronger R&D capabilities, and they may even be able to mass-produce the 2CV-Bing Hydrogen Molecule method — entering the market would only give the others a leg up.

After Yan Xuelin explained the encountered issues, the first one to speak was Li Ming who had worked on a biochemical project and had some related experience. He drew a line on the R&D saying, "Artificial synthesis is not possible, at least not in a short time. We still have to look for biological methods for our research."

Yan Xuelin nodded, "We don’t need to consider the issue of artificial synthesis and should focus on finding methods within our fields of expertise."

Artificial synthesis is simple and straightforward, but because of its simplicity, the difficulty is high. Not only does it take a long time, but the research institute also lacks related experience, and even lacks many necessary pieces of equipment.

Doing research from a biological experiment perspective is different.

The research institute excels in this direction.

A few researchers thought for a moment and quickly came up with a few ideas--

"We need to find a way to replace the human immune environment so that the 2CV-Bing Hydrogen Molecule can be produced normally," Han Hui suggested a way to reduce costs, as simulating a human immune environment is expensive. By replacing unnecessary parts, the cost of the simulation can be significantly reduced.

Dai Tianqing suggested, "We can study the immune reactions to bacteria in other vertebrates. We may find 2CV-Bing Hydrogen Molecule or a similar protein substance with anti-AIDS effects."

His suggestion was somewhat based on luck. freewēbnoveℓ.com

If they were lucky enough to discover that a mouse’s immune system can produce a similar small protein substance that fights against the AIDS virus, they could find many other research directions or directly mass-produce it.

Li Ming proposed a different idea, "We can study human bacterial antibodies. Bacterial antibodies are large protein molecules, produced together with the 2CV-Bing Hydrogen Molecule, which might lead to other discoveries."

This suggestion is somewhat vague, seemingly unrelated to drug development, but it might lead to new discoveries which cannot be ruled out. Developing drugs from a biological perspective is not as ’simple and direct’ as with artificial synthesis. More discoveries can help find better methods.

After all the researchers presented their opinions, everyone in the small conference room looked at Zhao Yi.

In fact, Zhao Yi rarely shared his opinions in such meetings, because of his limited knowledge and experience make it difficult for him to give good suggestions.

Zhao Yi thought for a moment and didn’t present his own opinion. Instead, he said directly, "I support Professor Li Ming’s opinion. We should study bacterial antibodies."

"Why?" Yan Xuelin asked with interest.

Zhao Yi thought for a moment and said, "Intuition, I guess."

"Intuition?"

Dai Tianqing couldn’t help but say, "Zhao Yi, we can’t rely on intuition for our research. We need science."

"Oh."

Zhao Yi nodded in acceptance, but still insisted, "But I still think we should mainly study bacterial antibodies, with the others as supplementary."

Yan Xuelin thought for a moment and nodded, "Everyone’s opinions are reasonable. Drug development is not a single research field, and breakthroughs can be made in different directions to reduce manufacturing costs."

"Let’s do this: We will break into three teams, each pursuing a different research direction according to their ideas, and we will combine our findings in the end."

Li Ming was the first to nod, "Zhao Yi and I share the same opinion, so we will work together."

Zhang Wei raised her hand, "I will be in this group too. Zhao Yi is busy with preparing academic reports, and our combined work experience is extensive."

"No, you guys, I thought..."

Ai Lixin couldn’t finish his sentence, he had wanted to join Zhao Yi’s group, but Li Ming was ahead of him, and Zhang Wei quickly raised her hand to declare her stance. Feeling somber, Han Hui said, "You’ll join my group then."

He could only nod helplessly, thinking that the direction of replacing the human environment in Han Hui’s group would at least not stagnate, better than joining Dai Tianqing’s group and relying on luck.

Dai Tianqing and Chen Zhigang looked at each other and nodded, "Then we’ll be a group."

...

After the internal meeting ended, everyone left the room.

As he left, Dai Tianqing said with a smile, "Zhao Yi, to be honest, when we conduct drug development projects, we don’t have as much experience as pharmaceutical companies. It’s difficult for us to catch up with the R&D capabilities of those companies. If they can’t do it in a short period, neither can we."

"So doing this requires relying on luck. We’ve split into three groups, and I think if the results can be successful, it must be our group."

Upon hearing this, Chen Zhigang felt that what Dai Tianqing said made sense and thought it might not be too bad to be in the same group.

Zhao Yi smiled and gave Dai Tianqing a thumbs-up, "Alright, I wish you success, let’s all work hard!"

"You guys work hard too!"

They exchanged glances and laughed together.